Alembic Pharmaceuticals informs about press release

15 Nov 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. Enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

897.70 -4.50 (-0.50%)
05-Dec-2025 13:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.00
Dr. Reddys Lab 1280.00
Cipla 1523.50
Zydus Lifesciences 934.30
Lupin 2102.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×